Athyrium Capital Management, LP Kala Pharmaceuticals, Inc. Transaction History

Athyrium Capital Management, LP

  • $4.1 Million
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021
SELL
$6.28 - $8.79 $8.37 Million - $11.7 Million
-1,333,333 Closed
0 $0
Q4 2018

Feb 12, 2019
BUY
$4.29 - $9.94 $5.72 Million - $13.3 Million
1,333,333 New
1,333,333 $6.52 Million

Others Institutions Holding KALA

# of Institutions
1
Shares Held
1
Call Options Held
0
Put Options Held
0
View Full List

About Kala Pharmaceuticals, Inc.

KALA Quotes by TradingView
  • Ticker KALA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,464,160
  • Market Cap $7.69M
  • Description
  • Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...
More about KALA
Track This Portfolio

Track Athyrium Capital Management, LP Portfolio

Follow Athyrium Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Athyrium Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Athyrium Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email